We further analysed IGFBP expression in the Pima DKD cohort [13], where we also found a reduction in glomerular IGFBP-1 in individuals with early-stage disease, compared with living donors (Table 1), which, notably, is unlikely to be purely a consequence of podocyte loss in this cohort. Here, IGFBP1 is linked to diabetic kidney disease.